Filing Details

Accession Number:
0001181431-13-033603
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-07 17:04:48
Reporting Period:
2013-06-05
Filing Date:
2013-06-07
Accepted Time:
2013-06-07 17:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS Pharmaceutical Preparations (2834) 900475355
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374539 R Andrew Allen C/O Clovis Oncology, Inc.
2525 28Th Street, Suite 100
Boulder CO 80301
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-05 700 $65.77 21,894 No 4 S Indirect By wife
Common Stock Disposition 2013-06-05 4,500 $66.89 17,394 No 4 S Indirect By wife
Common Stock Disposition 2013-06-05 6,494 $67.65 10,900 No 4 S Indirect By wife
Common Stock Disposition 2013-06-05 2,500 $68.84 8,400 No 4 S Indirect By wife
Common Stock Disposition 2013-06-05 5,800 $70.06 2,600 No 4 S Indirect By wife
Common Stock Disposition 2013-06-05 2,600 $70.72 0 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 181,919 Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.28 to $66.18, inclusive. The reporting person undertakes to provide to Clovis Oncology, Inc., any security holder of Clovis Oncology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.33 to $67.32, inclusive.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.36 to $68.20, inclusive.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.39 to $69.37, inclusive.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.46, inclusive.
  6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.49 to $71.11, inclusive.
  7. Represents shares owned directly by the reporting person.